Skip to content

Smartphone App for Adolescents With Idiopathic Scoliosis

Evaluating the Impact of a Smartphone App on Health Outcomes and Treatment Adherence in Adolescents With Idiopathic Scoliosis: A Mixed Method Quasi-Experimental Study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07686848
Enrollment
30
Registered
2026-07-07
Start date
2028-04-01
Completion date
2031-09-01
Last updated
2026-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescence Idiopathic Scoliosis, AIS

Keywords

scoliosis, app, digital health, treatment adherence, self-determination theory, self-efficacy, social support, theory driven

Brief summary

This study aims to evaluate a smartphone application (DinSkoliose) designed to support adolescents with idiopathic scoliosis (AIS) in managing their condition and following their treatment. Adolescents with AIS often find it challenging to adhere to conservative treatment, such as wearing a brace or performing physiotherapy exercises. The app was developed specifically for this study as a theory-informed digital health intervention to support self-management and treatment adherence. It includes features such as symptom tracking, educational content, reminders, and social support. Participants will use the app for 12 weeks in their everyday environment alongside their usual care. They will complete questionnaires before and after the intervention and participate in an interview to share their experiences. The study will examine whether the app can improve health-related behaviors, including treatment adherence and self-management, and whether it is feasible and acceptable for adolescents with scoliosis.The app is meant to complemen the current AIS treatment, doesn't substitute it.

Detailed description

This study is a quasi-experimental, one-group pretest-posttest study designed to evaluate the feasibility, acceptability, and preliminary effectiveness of a smartphone application (DinSkoliose) for adolescents with idiopathic scoliosis (AIS). AIS is a common spinal condition that often requires long-term conservative treatment, including brace use and physiotherapy scoliosis-specific exercises. Treatment success is highly dependent on adherence; however, adherence is often limited by physical discomfort, psychological factors, and lack of continuous support. The DinSkoliose app is a personalized, theory-informed digital health intervention developed specifically for this study using a user-centered co-design approach. The app is grounded in behavioral theories of motivation and self-management and includes features to support treatment adherence, such as tracking of brace use and exercises, monitoring of symptoms (e.g., pain and mood), educational information, reminders, and structured social support. Participants will use the app over a 12-week period in their natural environment alongside their usual care, with no additional clinical intervention. Outcomes will be assessed at baseline and post-intervention using validated questionnaires measuring health behaviors, self-management, self-efficacy, social support, and patient activation. App usability, engagement, and acceptability will also be evaluated. In addition, semi-structured interviews will be conducted after the intervention to explore participants' experiences and identify strengths and areas for improvement. The results will inform further development of the app and future evaluation in larger controlled studies.

Interventions

DEVICEDinSkoliose smartphone application

The intervention consists of the use of the DinSkoliose smartphone application, a personalized digital health tool specifically developed for this study. The app is designed to support adolescents with idiopathic scoliosis in managing their condition and improving adherence to conservative treatment. The app includes features for monitoring brace use and physiotherapy exercises, tracking symptoms such as pain and mood, providing educational content, sending reminders, and offering structured social support. Participants will use the app independently in their everyday environment over a 12-week period alongside their usual care. No additional treatment will be provided.

Sponsors

Oslo Metropolitan University
Lead SponsorOTHER
Oslo University Hospital
CollaboratorOTHER
Ryggforeningen i Norge, Norway
CollaboratorUNKNOWN

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Single-group, quasi-experimental study with a pretest-posttest design (no comparator group)

Eligibility

Sex/Gender
ALL
Age
10 Years to 24 Years
Healthy volunteers
No

Inclusion criteria

The study population will consist of adolescent patients with AIS. The Inclusion criteria for participants in our study are those: 1. who are diagnosed with AIS; 2. who give written informed consent, 3. who are at the age between 10 - 24 years old; 4. under 16 years old for whom parental consent has been provided (as required by the National Research Ethics Committee); 5. who can speak, read, and write in Norwegian or English; 6. who have access to and ability to use smart phone; 7. who have internet access. The

Exclusion criteria

for participants in our study are those who: 1. have a history of other type of scoliosis (such as congenital, neuromuscular, degenerative); 2. are younger than 10 years old and older than 24 years old; 3. have any additional diagnosis that could affect the intervention outcome (severe mental health disorders or diagnosis of a developmental disorder that prevents understanding and compliance with intervention, leg length discrepancy).

Design outcomes

Primary

MeasureTime frameDescription
Change in Health Behaviors OutcomeBaseline to 12 weeksChange in health behaviour outcomes, including self-management, knowledge, skills, and confidence, measured using the Patient Activation Measure (PAM). PAM is a validated 13-item questionnaire with scores ranging from 0 to 100, where higher scores indicate greater patient activation and improved health behaviour.
Change in behavioral impact (such as self-management of AIS)Baseline to 12 weeksChange in self-efficacy, defined as participants' confidence in their ability to manage their condition, perform health-related behaviors, and cope with symptoms, measured using the Chronic Disease Self-Efficacy Scale (CDSES). Scores range from 1 to 10, with higher scores indicating greater self-efficacy.
Change in motivation for exercise measured by SDT-based Motivation for Exercise questionnaireBaseline to 12 weeksChange in motivation for exercise measured using a Self-Determination Theory (SDT)-based Motivation for Exercise questionnaire, assessing different types of motivational regulation (external, introjected, identified, and intrinsic motivation). Scores reflect the degree of autonomous versus controlled motivation, with higher autonomous motivation indicating more self-determined and sustainable health behaviour.

Secondary

MeasureTime frameDescription
User engagement measured by User Engagement Scale (UES)Week 6 and Week 12User engagement measured using the User Engagement Scale (UES), a validated questionnaire assessing multiple dimensions of engagement including focused attention, perceived usability, aesthetic appeal, and reward-related engagement. Responses are rated on a Likert scale, and higher scores indicate greater user engagement with the intervention.
Change in perceived social support measured by Medical Outcomes Study Social Support Survey (MOS-SSS)Baseline to 12 weeksChange in perceived social support measured using the Medical Outcomes Study Social Support Survey (MOS-SSS), a validated questionnaire assessing emotional/informational support, tangible support, positive social interaction, and affectionate support. Scores are calculated on a Likert scale, with higher scores indicating greater perceived social support.
App usability and acceptability measured by Mobile App Rating Scale (MARS)Week 6 and Week 12App usability and acceptability measured using the Mobile App Rating Scale (MARS), which evaluates app quality across multiple domains including engagement, functionality, aesthetics, and information quality. Items are rated on a 5-point scale, with higher scores indicating better app quality and acceptability.
Participant experiences and perceived impact assessed through semi-structured interviewsAt 12 weeks (post-intervention)Participant experiences, perceptions, and perceived impact of the intervention assessed through semi-structured qualitative interviews. Interviews explore app usability, engagement, perceived effects on health behaviour, self-management, and psychosocial well-being. Data will be analyzed using thematic analysis.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 8, 2026